Clear Creek Bio
MA - CambridgeBiotechnology
Focus: Clear Creek Bio is a Cambridge-based small molecule biotech focused on infectious diseases and oncology, currently in early-stage development with a pipeline centered on Brequinar.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Clear Creek Bio
AI assessmentNot HiringNo open roles listed right now. Follow Clear Creek Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Brequinar
COVID-19Clinical Trials (1)
NCT04425252Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
Phase 1/2Help build intelligence for Clear Creek Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.